Estimating the Economic Value of CDX2 as a Predictive Biomarker to Guide Treatment Decisions in Stage II Colon Cancer

Value Health. 2022 Mar;25(3):382-384. doi: 10.1016/j.jval.2021.09.006. Epub 2021 Nov 2.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor
  • CDX2 Transcription Factor / biosynthesis*
  • Colonic Neoplasms / mortality
  • Colonic Neoplasms / pathology*
  • Colonic Neoplasms / therapy
  • Humans
  • Neoplasm Staging
  • Prognosis
  • Survival Analysis

Substances

  • Biomarkers, Tumor
  • CDX2 Transcription Factor